Status:
COMPLETED
Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Delicata Pocket BR
Lead Sponsor:
Sanofi
Conditions:
Hygiene
Eligibility:
FEMALE
18-60 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Delicata Pocket.
Eligibility Criteria
Inclusion
- Integral skin test in the region;
Exclusion
- Lactation or gestational risk or gestation;
- Use of Anti-inflammatory or immunosuppression drugs 1 month before the study;
- Topical medication use at the region to be treated;
- Cutaneous disease or active gynecological disease which may interfere in study results;
- Personal history of allergic disease at the area to be treated;
- Allergic or atopic history;
- The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00663390
Start Date
December 1 2007
Last Update
January 29 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanofi-aventis
São Paulo, São Paulo, Brazil